Economic Burden of Urgency Urinary Incontinence in the United States: A Systematic Review

por Coyne, Karin S., Wein, Alan, Nicholson, Sean, Kvasz, Marion, Chen, Chieh-I, Milsom, Ian
Publicado 2014

Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain

por Sicras-Mainar, Antoni, Rejas, Javier, Navarro-Artieda, Ruth, Aguado-Jodar, Alba, Ruiz-Torrejón, Amador, Ibáñez-Nolla, Jordi, Kvasz, Marion
Publicado 2013